LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study (Q63818436)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study |
clinical trial |
Statements
Multicenter, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 12 µg LNG/Day Initial in Vitro Release Rate (LCS12) in Comparison to a Combined Oral Contraceptive Containing 30 µg Ethinyl Estradiol and 3 mg Drospirenone (Yasmin®) in Young Women (18-29 Years) Over 18 Months of Use (English)
0 references
6 January 2011
0 references
8 January 2013
0 references
567
0 references
18 year
0 references
29 year
0 references